Jobs
-
Insys Therapeutics has filed for Chapter 11 bankruptcy and plans to sell “substantially all of the company’s assets,” the company said. Insys’s pipeline includes inhaled dronabinol, intranasal epinephrine, and intranasal naloxone. NDA submissions for the… Read more . . .
-
AptarGroup has announced its acquisition of Nanopharm and Gateway Analytical as “part of Aptar’s strategy to broaden its portfolio of services that support pharmaceutical and biotech customers to accelerate and derisk their complex product developments.”… Read more . . .
-
Theravance Biopharma has named former Acorda Therapeutics Chief Business Officer Andrew Hindman as Senior VP and Chief Financial Officer. Hindman, who led Acorda’s acquisition of Inbrija inhaled L-dopa developer Civitas Therapeutics in 2014, also previously served as President… Read more . . .
-
Medical Developments International (MVP) announced that Mundipharma has acquired exclusive Australian distribution rights for the Penthrox methoxyflurane inhaler. Mundipharma already has the rights to market Penthrox in most of Europe. Mundipharma Australia and New Zealand… Read more . . .
-
Windtree Therapeutics and Eleison Pharmaceuticals have announced results from a study that demonstrated the feasibility of delivering Eleison’s inhaled lipid cisplatin (ILC) via Windtree’s Aerosol Delivery System (ADS). In March 2018, the companies announced that… Read more . . .
-
Verona Pharma has initiated a Phase 2 trial of the MDI formulation of RPL554 ensifentrine in COPD patients, the company said. Verona recently announced the initiation of a Phase 2b study of nebulized ensifentrine and… Read more . . .
-
ARS Pharmaceuticals has announced results from the EPI-04 clinical study demonstrating that the company’s ARS-1 intranasal epinephrine spray has a pharmacokinetic profile that is similar to intramuscular epinephrine. ARS is developing ARS-1 for the treatment… Read more . . .
-
The Brazilian Health Regulatory Agency (ANVISA) has approved Afrezza inhaled insulin for the treatment of diabetes, and the DPI is expected to be launched in Brazil by the end of 2019, MannKind Corporation said. MannKind announced… Read more . . .
-
Clement Clarke has announced the launch of its Clip-Tone technique guidance whistle for use with GSK’s Evohaler Ventolin and Seretide MDIs in the UK. The Clip-Tone will be available by prescription only. Like the company’s… Read more . . .
-
Novartis has announced that the Phase 3 QUARTZ study met its primary and secondary endpoints, demonstrating that low dose QMF149 indacaterol/mometasone furoate delivered via the Breezhaler DPI produced statistically significant and clinically meaningful lung function… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
May 10-May 14: RDD 2026, Phoenix, AZ, USA
May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA
May 17-May 20: ATS International Conference 2026, Orlando, FL, USA
June 9-June 10: Nasal Drug Delivery Symposium: Current Status and Future Opportunities, Stockholm, Sweden
June 10: SMI.London 2026, London, UK